Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Equity Ratio: 2016-2021

Historic Equity Ratio for ENDRA Life Sciences (NDRA) over the last 5 years, with Sep 2021 value amounting to 0.86.

  • ENDRA Life Sciences' Equity Ratio rose 38.10% to 0.86 in Q3 2021 from the same period last year, while for Sep 2021 it was 0.86, marking a year-over-year increase of 38.10%. This contributed to the annual value of 0.82 for FY2020, which is 23.30% up from last year.
  • Latest data reveals that ENDRA Life Sciences reported Equity Ratio of 0.86 as of Q3 2021, which was down 1.18% from 0.87 recorded in Q2 2021.
  • ENDRA Life Sciences' Equity Ratio's 5-year high stood at 0.98 during Q2 2017, with a 5-year trough of -2.53 in Q1 2017.
  • Its 3-year average for Equity Ratio is 0.68, with a median of 0.66 in 2019.
  • Per our database at Business Quant, ENDRA Life Sciences' Equity Ratio slumped by 136.96% in 2018 and then soared by 209.53% in 2019.
  • Quarterly analysis of 5 years shows ENDRA Life Sciences' Equity Ratio stood at 0.86 in 2017, then climbed by 0.42% to 0.87 in 2018, then declined by 23.31% to 0.66 in 2019, then rose by 23.30% to 0.82 in 2020, then spiked by 38.10% to 0.86 in 2021.
  • Its Equity Ratio was 0.86 in Q3 2021, compared to 0.87 in Q2 2021 and 0.94 in Q1 2021.